Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of coronary artery disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor®System calculates a patient-specific CAD-score non-invasively in less than 10 minutes and can help rule out more than one third of patients with at least 96% certainty (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).
Company’s Keywords:
healthcare, acoustics, heart murmurs, diagnostic aid, stable chestpain, coronary artery disease
21
medical devices
335000
Outlook, Microsoft Office 365, Woo Commerce, Nginx, WordPress.org, YouTube, Google Tag Manager, CampaignMonitor, Google Maps, Mobile Friendly, Google Maps (Non Paid Users), Gravity Forms
2009
Your request has been submitted successfully.
Own or work here?